Old Web
English
Sign In
Acemap
>
authorDetail
>
Mingwei Wei
Mingwei Wei
Centers for Disease Control and Prevention
Medicine
Vaccination
Immunology
Adverse effect
Clinical trial
4
Papers
5
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials.
2021
Signal Transduction and Targeted Therapy
Fan-Yue Meng
Fan Gao
Siyue Jia
Xiang-Hong Wu
Jingxin Li
Xiling Guo
Jia-Lu Zhang
Bopei Cui
Zhi-Ming Wu
Mingwei Wei
Zhilong Ma
Hai-Lin Peng
Hongxing Pan
Lin Fan
Jing Zhang
Jiu-Qin Wan
Zhongkui Zhu
Xuewen Wang
Fengcai Zhu
Show All
Source
Cite
Save
Citations (1)
[Progress in research of influential factors for non- or low-immune response to hepatitis B vaccination].
2021
Chinese journal of epidemiology
Jin-tian Li
Mingwei Wei
F. C. Zhu
Show All
Source
Cite
Save
Citations (0)
An evaluation of a test-negative design for EV-71 vaccine from a randomized controlled trial.
2021
Human Vaccines & Immunotherapeutics
Li Zhang
Mingwei Wei
Pengfei Jin
Jingxin Li
Fengcai Zhu
Show All
Source
Cite
Save
Citations (0)
The vaccines-associated Arthus reaction
2019
Human Vaccines & Immunotherapeutics
Baozhen Peng
Mingwei Wei
Feng-Cai Zhu
Jing-Xin Li
Show All
Source
Cite
Save
Citations (4)
1